Rapalogues for Autism Phenotype in TSC: A Feasibility Study

Trial Profile

Rapalogues for Autism Phenotype in TSC: A Feasibility Study

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Everolimus (Primary) ; Sirolimus (Primary)
  • Indications Pervasive child development disorders; Tuberous sclerosis
  • Focus Therapeutic Use
  • Acronyms RAPT
  • Most Recent Events

    • 06 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 01 Sep 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top